Requests To Ease Japan's OTC Distribution Law Top Spurs Government To Action
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan's Ministry of Health, Labor and Welfare's recent Pharmaceutical Law amendments, which sharply toughened over-the-counter drug distribution regulations, have drawn a plethora of requests for revisions to the amendments, the government's Regulatory Reform Council announced July 16. The Cabinet Office - Japan's executive branch - will urge MHLW to relax the new restrictions next week, Yasuhiro Ogura, a council secretariat official in charge of structural reform said July 17
You may also be interested in...
Japan Opposition Party To Overhaul National Insurance Agency If It Wins Election, Lawmaker Says
TOKYO - As a means of maintaining the National Health Insurance program and improving Japan's healthcare services, the Social Central Medical Insurance Agency (Chuikyo) structure needs to be streamlined and independent persons, not interested parties alone, should serve as members, Democratic Party of Japan lawmaker Yukio Edano said July 7
MHLW Introduces Tougher Sales Requirements For OTC Drugs
TOKYO - Japan's Ministry of Health, Labor and Welfare enacted re-amended regulations of the Pharmaceutical Administration Law, effective June 1, which in principle require over-the-counter pharmaceutical sales in face-to-face transactions between pharmacists and registered salespersons and consumers but set a two-year grace period for distribution via the Internet and mail order and to remote, sparsely populated areas
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).